Protective role of microRNA‑219‑5p inhibitor against spinal cord injury via liver receptor homolog‑1/Wnt/β‑catenin signaling pathway regulation

Li,Jie; Li,Liqiang; Shen,Yong

doi:10.3892/etm.2018.5829

Protective role of microRNA‑219‑5p inhibitor against spinal cord injury via liver receptor homolog‑1/Wnt/β‑catenin signaling pathway regulation

Authors:
- Jie Li
- Liqiang Li
- Yong Shen
View Affiliations

Affiliations: Department of Spinal Surgery, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei 050051, P.R. China
Published online on: February 1, 2018 https://doi.org/10.3892/etm.2018.5829
Pages: 3563-3569

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the role of microRNA (miR)‑219‑5p in spinal cord injury (SCI) and to examine the underlying molecular mechanism. SCI rat and cell models were conducted in the current study, while reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) was used to detect the level of miR‑219‑5p in the SCI mice and neurons. Bioinformatics analysis was applied to predict the target genes of miR‑219‑5p, and dual‑luciferase reporter assay was performed to verify the prediction. In addition, MTT assay and flow cytometry were conducted to determine the cell viability and cell apoptosis of the neurons, respectively. Western blot analysis was also performed to detect the expression of associated proteins. The study results demonstrated that miR‑219‑5p was highly expressed in SCI mice and neurons, and directly targets liver receptor homolog‑1 (LRH‑1). The neuron viability was significantly reduced by SCI, however, it was recovered upon transfection with an miR‑219‑5p inhibitor. Neuron apoptosis was notably induced by SCI and inhibited by miR‑219‑5p inhibition. The LRH‑1/Wnt/β‑catenin signaling pathway was also inhibited by SCI, while it was significantly enhanced by the miR‑219‑5p inhibitor. Furthermore, LRH‑1 overexpression eliminated the effects of the miR‑219‑5p inhibitor on SCI. In conclusion, these data indicated that the miR‑219‑5p inhibitor served a protective role in SCI via regulating the LRH‑1/Wnt/β‑catenin signaling pathway.

View Figures

View References

1	Hulsebosch CE: Recent advances in pathophysiology and treatment of spinal cord injury. Adv Physiol Educ. 26:238–255. 2002. View Article : Google Scholar : PubMed/NCBI
2	Dumont RJ, Okonkwo DO, Verma S, Hurlbert RJ, Boulos PT, Ellegala DB and Dumont AS: Acute spinal cord injury, part I: Pathophysiologic mechanisms. Clin Neuropharmacol. 24:254–264. 2001. View Article : Google Scholar : PubMed/NCBI
3	Bareyre FM and Schwab ME: Inflammation, degeneration and regeneration in the injured spinal cord: Insights from DNA microarrays. Trends Neurosci. 26:555–563. 2003. View Article : Google Scholar : PubMed/NCBI
4	W.H.O., . Spinal Cord Injury Fact Sheet N 384. 2013.
5	Ozdemir M, Attar A and Kuzu I: Regenerative treatment in spinal cord injury. Curr Stem Cell Res Ther. 7:364–369. 2012. View Article : Google Scholar : PubMed/NCBI
6	Pereira JE, Costa LM, Cabrita AM, Couto PA, Filipe VM, Magalhães LG, Fornaro M, Di Scipio F, Geuna S, Maurício AC and Varejão AS: Methylprednisolone fails to improve functional and histological outcome following spinal cord injury in rats. Exp Neurol. 220:71–81. 2009. View Article : Google Scholar : PubMed/NCBI
7	Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
8	Krol J, Loedige I and Filipowicz W: The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 11:597–610. 2010. View Article : Google Scholar : PubMed/NCBI
9	Winter J, Jung S, Keller S, Gregory RI and Diederichs S: Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol. 11:228–234. 2009. View Article : Google Scholar : PubMed/NCBI
10	Wang W, Kwon EJ and Tsai LH: MicroRNAs in learning, memory, and neurological diseases. Learn Mem. 19:359–368. 2012. View Article : Google Scholar : PubMed/NCBI
11	Rao P, Benito E and Fischer A: MicroRNAs as biomarkers for CNS disease. Front Mol Neurosci. 6:392013. View Article : Google Scholar : PubMed/NCBI
12	Dong J, Lu M, He X, Xu J, Qin J, Cheng Z, Liang B, Wang D and Li H: Identifying the role of microRNAs in spinal cord injury. Neurol Sci. 35:1663–1671. 2014. View Article : Google Scholar : PubMed/NCBI
13	Ning B, Gao L, Liu RH, Liu Y, Zhang NS and Chen ZY: microRNAs in spinal cord injury: Potential roles and therapeutic implications. Int J Biol Sci. 10:997–1006. 2014. View Article : Google Scholar : PubMed/NCBI
14	Nieto-Diaz M, Esteban FJ, Reigada D, Muñoz-Galdeano T, Yunta M, Caballero-López M, Navarro-Ruiz R, Del Águila A and Maza RM: microRNA dysregulation in spinal cord injury: Causes, consequences and therapeutics. Front Cell Neurosci. 8:532014. View Article : Google Scholar : PubMed/NCBI
15	Wang Q, Zhu L, Jiang Y, Xu J, Wang F and He Z: miR-219-5p suppresses the proliferation and invasion of colorectal cancer cells by targeting calcyphosin. Oncol Lett. 13:1319–1324. 2017. View Article : Google Scholar : PubMed/NCBI
16	Li C, Dong J, Han Z and Zhang K: MicroRNA-219-5p represses the proliferation, migration and invasion of gastric cancer cells by targeting the LRH-1/Wnt/β-catenin signaling pathway. Oncol Res. 25:617–627. 2017. View Article : Google Scholar : PubMed/NCBI
17	Huang C, Cai Z, Huang M, Mao C, Zhang Q, Lin Y, Zhang X, Tang B, Chen Y, Wang X, et al: miR-219-5p modulates cell growth of papillary thyroid carcinoma by targeting estrogen receptor α. J Clin Endocrinol Metab. 100:E204–E213. 2015. View Article : Google Scholar : PubMed/NCBI
18	Huang N, Lin J, Ruan J, Su N, Qing R, Liu F, He B, Lv C, Zheng D and Luo R: MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3. FEBS Lett. 586:884–891. 2012. View Article : Google Scholar : PubMed/NCBI
19	Hachisuka S, Kamei N, Ujigo S, Miyaki S, Yasunaga Y and Ochi M: Circulating microRNAs as biomarkers for evaluating the severity of acute spinal cord injury. Spinal Cord. 52:596–600. 2014. View Article : Google Scholar : PubMed/NCBI
20	Jee MK, Jung JS, Choi JI, Jang JA, Kang KS, Im YB and Kang SK: MicroRNA 486 is a potentially novel target for the treatment of spinal cord injury. Brain. 135:1237–1252. 2012. View Article : Google Scholar : PubMed/NCBI
21	Jaworski J and Sheng M: The growing role of mTOR in neuronal development and plasticity. Mol Neurobiol. 34:205–219. 2006. View Article : Google Scholar : PubMed/NCBI
22	Wang Z, Zhou L, Zheng X, Chen G, Pan R, Li J and Liu W: Autophagy protects against PI3K/Akt/mTOR-mediated apoptosis of spinal cord neuronsafter mechanical injury. Neurosci Lett. 656:158–164. 2017. View Article : Google Scholar : PubMed/NCBI
23	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
24	Zhai G, Song J, Shu T, Yan J, Jin X, He J and Yin Z: LRH-1senses signaling from phosphatidylcholine to regulate the expansion growth of digestive organs via synergy with Wnt/β-catenin signaling in zebrafish. J Genet Genomics. 20:307–317. 2017. View Article : Google Scholar
25	Kramer HB, Lai CF, Patel H, Periyasamy M, Lin ML, Feller SM, Fuller-Pace FV, Meek DW, Ali S and Buluwela L: LRH-1 drives colon cancer cell growth by repressing the expression of the CDKN1A gene in a p53-dependent manner. Nucleic Acids Res. 44:582–594. 2016. View Article : Google Scholar : PubMed/NCBI
26	Harkema SJ: Neural plasticity after human spinal cord injury: Application of locomotor training to the rehabilitation of walking. Neuroscientist. 7:455–468. 2001. View Article : Google Scholar : PubMed/NCBI
27	Martirosyan NL, Carotenuto A, Patel AA, Kalani MY, Yagmurlu K, Lemole GM Jr, Preul MC and Theodore N: The role of microRNA markers in the diagnosis, treatment and outcome prediction of spinal cord injury. Front Surg. 3:562016. View Article : Google Scholar : PubMed/NCBI
28	Liu D, Huang Y, Jia C, Li Y, Liang F and Fu Q: Administration of antagomir-223 inhibits apoptosis, promotes angiogenesis andfunctional recovery in rats with spinal cord injury. Cell Mol Neurobiol. 35:483–491. 2015. View Article : Google Scholar : PubMed/NCBI
29	Yang Z, Xu J, Zhu R and Liu L: Down-regulation of miRNA-128 contributes to neuropathic pain following spinal cord injury via activation of P38. Med Sci Monit. 23:405–411. 2017. View Article : Google Scholar : PubMed/NCBI
30	Zhou HJ, Wang LQ, Xu QS, Fan ZX, Zhu Y, Jiang H, Zheng XJ, Ma YH and Zhan RY: Downregulation of miR-199b promotes the acute spinal cord injury through IKKβ-NF-κB signaling pathway activating microglial cells. Exp Cell Res. 349:60–67. 2016. View Article : Google Scholar : PubMed/NCBI
31	Tao B and Shi K: Decreased miR-195 expression protects rats from spinal cord injury primarily by targeting HIF-1α. Ann Clin Lab Sci. 46:49–53. 2016.PubMed/NCBI
32	Boon H, Sjögren RJ, Massart J, Egan B, Kostovski E, Iversen PO, Hjeltnes N, Chibalin AV, Widegren U and Zierath JR: MicroRNA-208b progressively declines after spinal cord injury in humans and is inversely related to myostatin expression. Physiol Rep. 3:pii e126222015. View Article : Google Scholar
33	Wang T, Yuan W, Liu Y, Zhang Y, Wang Z, Chen X, Feng S, Xiu Y and Li W: miR-142-3p is a potential therapeutic target for sensory function recovery of spinal cord injury. Med Sci Monit. 21:2553–2556. 2015. View Article : Google Scholar : PubMed/NCBI
34	Rao SA, Arimappamagan A, Pandey P, Santosh V, Hegde AS, Chandramouli BA and Somasundaram K: miR-219-5p inhibits receptor tyrosine kinase pathway by targeting EGFR in glioblastoma. PLoS One. 8:e631642013. View Article : Google Scholar : PubMed/NCBI
35	Cheng J, Deng R, Zhang P, Wu C, Wu K, Shi L, Liu X, Bai J, Deng M, Shuai X, et al: miR-219-5p plays a tumor suppressive role in colon cancer by targeting oncogene Sall4. Oncol Rep. 34:1923–1932. 2015. View Article : Google Scholar : PubMed/NCBI
36	Nadolny C and Dong X: Liver receptor homolog-1 (LRH-1): A potential therapeutic target for cancer. Cancer Biol Ther. 16:997–1004. 2015. View Article : Google Scholar : PubMed/NCBI
37	Botrugno OA, Fayard E, Annicotte JS, Haby C, Brennan T, Wendling O, Tanaka T, Kodama T, Thomas W, Auwerx J and Schoonjans K: Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferation. Mol Cell. 15:499–509. 2004. View Article : Google Scholar : PubMed/NCBI